Stock analysts at StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI – Get Free Report) in a note issued to investors on Thursday. The firm set a “hold” rating on the stock.
China Pharma Price Performance
Shares of China Pharma stock opened at $0.18 on Thursday. China Pharma has a 52-week low of $0.17 and a 52-week high of $1.16. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.24 and a current ratio of 0.84. The stock’s 50-day simple moving average is $0.23 and its 200 day simple moving average is $0.25.
China Pharma (NYSE:CPHI – Get Free Report) last posted its earnings results on Wednesday, August 14th. The company reported ($0.09) earnings per share (EPS) for the quarter. The company had revenue of $0.93 million for the quarter. China Pharma had a negative return on equity of 61.46% and a negative net margin of 85.56%.
China Pharma Company Profile
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Read More
- Five stocks we like better than China Pharma
- Retail Stocks Investing, Explained
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- What to Know About Investing in Penny Stocks
- Top-Performing Non-Leveraged ETFs This Year
- Why Are These Companies Considered Blue Chips?
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
